Search for opportunities to participate in a digestive systems and liver disease research study.
UT Southwestern Medical Center’s Clinic for Liver Diseases offers the most advanced diagnostic and treatment options for all types of liver disease.
By preventing or delaying additional liver damage and related complications through innovative therapies, our liver disease specialists are able to markedly improve patients’ health and quality of life. Our compassionate team provides comprehensive patient-centered care with a focus on patient education.
Leaders in Liver Disease Research and Patient Care
UT Southwestern is dedicated to treating, curing, and restoring a sense of health for all who suffer from liver disease.
We are at the forefront of liver disease treatment and research. Our faculty has a long history of advancements in the field, translating groundbreaking scientific insights into superior patient care. Our team includes:
- Willis Maddrey, M.D., whose research in alcoholic liver disease established
the Maddrey score, a calculation used by doctors worldwide to determine the severity
of alcoholic hepatitis.
- Helen Hobbs, M.D., and Jay Horton, M.D., pioneers in fatty liver disease research. Dr. Hobbs and
her team have uncovered genetic risk factors
and novel potential treatment targets for fatty liver disease.
- William Lee, M.D., a renowned expert in acute liver failure and principal
investigator of the Acute Liver Failure Study Group. Dr. Lee is also a leader
in clinical research and management of hepatitis B and C as the founder of the
Liver Unit for clinical trials at UT Southwestern Medical Center.
- Jorge Marrero, M.D., an expert in the field of hepatocellular carcinoma
research and management and liver transplant medicine. Under his medical
directorship, the UT Southwestern Liver Transplant program has emerged as a
center of excellence.
- Amit Singal, M.D., a premier researcher in hepatocellular carcinoma
screening. He is among the top
contributors to the literature worldwide. He is also Medical Director of the
Liver Tumor Program at UT Southwestern.
- Marlyn Mayo, M.D., an expert in the field of autoimmune-mediated and
cholestatic liver disease. She has contributed significantly to the literature
and body of knowledge for the management of primary biliary cholangitis,
primary sclerosing cholangitis, and autoimmune hepatitis. She is a sought-after
speaker nationally and internationally.
- Mack Mitchell, M.D., a leader in clinical research on the forefront of
understanding and managing alcoholic liver disease. Dr. Mitchell and his
collaborators continue to investigate novel treatments for a disease with
limited treatment options and a high mortality.
Liver diseases treated at UT Southwestern include:
- Acute liver
failure: Rare but serious rapid
deterioration of liver function in someone with no pre-existing liver disease
- Alcoholic liver
disease: Liver damage caused by
excessive alcohol use
- Autoimmune hepatitis: A chronic disease that occurs when the immune system attacks
- Cirrhosis of the liver: A gradual disease in which healthy liver cells
are replaced by scar tissue, which can result from any chronic liver disease
and not just from excessive alcohol intake
- Drug-induced liver injury: A rare adverse drug reaction seen with prescription
medication or non-prescription, over-the-counter supplements and herbs; sometimes
associated with acetaminophen use
- Fatty liver: A disease
characterized by the buildup of fat in the liver tissue
- Hemochromatosis: A disorder in
which the body absorbs and stores too much iron
- Viral hepatitis: An infection
that causes inflammation of the liver; typically caused by the hepatitis A, B,
or C viruses
cancer: Cancer that begins in the cells of the liver
- Liver tumors: Abnormal growths
on or in the liver; these can be cancerous or noncancerous
- Primary biliary cholangitis: A chronic disease caused by progressive scarring of the liver’s bile ducts
- Primary sclerosing cholangitis: A chronic disease in which inflammation causes
scarring within the liver’s bile ducts
- Wilson’s disease: A rare genetic
disorder in which copper builds up in the liver, brain, and other vital organs
Our collaborative approach incorporates gastroenterologists, hepatologists, radiologists, hepatobiliary surgeons, and pathologists.
Our specialists provide the latest therapies, including immunosuppressant medications and advanced procedures to treat portal hypertension and ascites (complications of cirrhosis).
Established in 2007, our Liver Transplant Program has performed hundreds of lifesaving liver transplants to patients with end-stage liver failure. Our highly trained specialists use the most advanced surgical techniques and technologies, and our program has a three-year patient survival rate that surpasses the national average. As our transplant program continues to grow, we look forward to offering our patients the game-changing possibility of living donor liver transplant.
Unit at UT Southwestern Medical Center has been part of more than 40 clinical trials in the past
20 years and been instrumental in major national research networks in hepatitis
B and C, drug-induced liver injury, and acute liver failure. No other center in
Texas can make this claim.
Showing 4 locations
El Paso, Texas 79902